Tessa Therapeutics
Signal active
Organization
Contact Information
Overview
Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors. The company's therapy specializes in developing virus specific T-cells and CAR T cells for the treatment of lymphoma, enabling healthcare providers to treat cancer patients and improve their lives.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2001
Employees
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
Tessa Therapeutics headquartered in Asia, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $15.4B in funding across 60 round(s). With a team of 101-250 employees, Tessa Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Tessa Therapeutics, raised $74.4K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
1
Lead Investors
0
Total Funding Amount
$256.1M
Details
3
Tessa Therapeutics has raised a total of $256.1M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Private Equity | 80.0M | ||
| 2018 | Late Stage Venture | |||
| 2022 | Early Stage Venture | 126.0M |
Investors
Tessa Therapeutics is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Tessa Therapeutics | - | FUNDING ROUND - Tessa Therapeutics | 126.0M |
| Conor McKechnie | - | FUNDING ROUND - Conor McKechnie | 74.4K |
| Tessa Therapeutics | - | FUNDING ROUND - Tessa Therapeutics | 74.4K |
| Cytiva BioChallenge | - | FUNDING ROUND - Cytiva BioChallenge | 74.4K |
Recent Activity
There is no recent news or activity for this profile.